{
    "2020-08-20": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】集采加速下，探讨仿制药板块的投资主线",
                "features": {
                    "keywords": [
                        "集采",
                        "仿制药",
                        "投资主线"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "15亿买下3000家药店，美尔雅要转型？",
                "features": {
                    "keywords": [
                        "美尔雅",
                        "药店收购",
                        "转型"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "零售",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}